Empower Drug Development:
Empower Drug Development:
Diverse Portfolio
of Hepatic Products
Empower Drug Development:
Empower Drug Development:
PROTECT THE
VITALITY OF CELLS

SCROOL

About MileCell Bio
MILECELL BIOTECHNOLOGY INC.

Founded in 2014, MileCell Biotechnology is a high-tech enterprise dedicated to high-quality human & animal primary cell solutions, providing products & CRO services to pharmaceutical companies and research laboratories, support preclinical research, clinical studies from Phase I to Phase III, and commercialization.

We specialize in:
• Human Peripheral blood apheresis collection & Human/Animal immune cells isolation/purification services, eg. high-quality PBMCs and other immune cell subsets, including T cells, B cells, NK cells, Monocytes, CD34+ cells and many other cell types;
• In vitro hepatic modeling solutions, including Animal hepatocytes, Non-parenchymal cells (NPCs) and Subcellular fractions;
• Media/Reagents/Kits for cell culture needs:
-Cell Culture Media (Specialty & Supplement varieties). Each product is designed for optimal nutrition and growth of primary cells.
-Kryogene™ Cell Freezing Media-CGT (DMF# 040563), a highly efficient, safe, and easy-to-use serum-free cryopreservation media optimized for the special requirements of a variety of cell and gene therapy drugs (CAR-T, CAR-NK, MSC, iPSC, etc).

About MileCell Bio
We Offering
Since 2014, MileCell Bio has invested the Shanghai R&D center, devoted to develop primary cell-related products and technologies, committed to providing integrated solutions based on primary cells.
Cell Products
Media / Reagents / Kits
Independent R&D Brand

2014

Established in

5000

m2
Laboratory

1200

+
Partners

30

%
Investment
Upcoming Events
American Association for Cancer Research (AACR)
American Association for Cancer Research (AACR)
Time
April 25-30, 2025
Address
McCormick Place Convention Center, Chicago